Pregnancy Complications - A Probiotic Interventional Study

• Status: Active, not recruiting
• Trial end date: 2021-09-27
• Target enrollment: 0
• Participant gender: Female

Summary

Investigators hypothesize that

a) probiotics decrease the overall inflammatory state in the pregnant woman, especially in women with high risk pregnancies.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sahlgrenska University Hospital, Sweden

Criteria

Inclusion Criteria:

• Maternal age > or = 18 y

• Singleton pregnancy

• Nulli or multiparous without maternal intercurrent diseases or pregnant women with a history of spontaneous preterm delivery or pregnant women with a history of preeclampsia.

Exclusion Criteria

• Multiple pregnancy

• Gestational age > 17+6 weeks at first visit

• Chronic intermittent diseases (e.g. diabetes mellitus, systemic lupus erythematosus, rheumatoid arthritis, Chron disease, ulcerative colitis)

• Uterus malformations

• Immunomodulatory medication

• Hormonal treatment (e.g. crinone, progesterone)

• Subject disagrees to stop intake of other products containing probiotics during study time.

• Subject is unable to provide written informed consent